| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 1708971-55-4 | Roblitinib(FGF 401) |
≥98% | | 询价 |
| 2 | 183321-74-6 | Erlotinib(OSI744,Tarceva) |
≥98% | | 询价 |
| 3 | 194423-06-8 | CL-387785(EKI-785) |
≥98% | | 询价 |
| 4 | 850140-73-7 | Afatinib(BIBW2992)Dimaleate |
≥98% | | 询价 |
| 5 | 1421373-98-9 | AZ5104 |
≥98% | | 询价 |
| 6 | 231277-92-2 | Lapatinib(GW-572016,Tykerb,Tyverb) |
≥98% | | 询价 |
| 7 | 267243-28-7 | Canertinib(CI-1033 PD-183805) |
≥98% | | 询价 |
| 8 | 1626387-80-1 | Zorifertinib(AZD3759 AZD-3759 zorifertinibum) |
≥98% | | 询价 |
| 9 | 698387-09-6 | Neratinib(HKI-272 PB272 Nerlynx) |
≥98% | | 询价 |
| 10 | 850140-72-6 | Afatinib(BIBW2992) |
≥98% | | 询价 |
| 11 | 388082-77-7 | Lapatinib Ditosylate(GW-572016,Tykerb) |
≥98% | | 询价 |
| 12 | 184475-35-2 | Gefitinib(ZD 1839) |
≥98% | | 询价 |
| 13 | 183319-69-9 | Erlotinib HCl(OSI-744,Tarceva) |
≥98% | | 询价 |
| 14 | 33069-62-4 | Paclitaxel |
| 10mg, 50mg, 100mg | 询价 |
| 15 | 332012-40-5 | Telatinib(BAY 57-9352) |
≥98% | | 询价 |
| 16 | 187389-52-2 | Z-VAD-FMK |
| 1mg, 5mg, 10mg | 询价 |
| 17 | 857876-30-3 | Motesanib Diphosphate(AMG-706) |
≥98% | | 询价 |
| 18 | 656247-17-5 | Nintedanib(Vargatef BIBF 1120) |
≥98% | | 询价 |
| 19 | 763113-22-0 | AZD2281(Olaparib) |
| 10mg, 25mg, 50mg, 100mg | 询价 |
| 20 | 796967-16-3 | Linifanib(ABT-869 AL-39324) |
≥98% | | 询价 |
| 21 | 1291074-87-7 | ENMD-2076 Tartrate |
≥98% | | 询价 |
| 22 | 286370-15-8 | KRN 633 |
≥98% | | 询价 |
| 23 | 1195765-45-7 | Dabrafenib |
| 5mg, 10mg, 25mg, 50mg | 询价 |
| 24 | 1140909-48-3 | Cabozantinib malate(XL184) |
≥98% | | 询价 |
| 25 | 690206-97-4 | ZM 306416(CB676475) |
≥98% | | 询价 |
| 26 | 928037-13-2 | Golvatinib(E7050) |
≥98% | | 询价 |
| 27 | 193000-39-4 | ZM 323881 HCl |
≥98% | | 询价 |
| 28 | 204005-46-9 | Semaxanib(SU-5416) |
≥98% | | 询价 |
| 29 | 1433953-83-3 | SAR131675 |
≥98% | | 询价 |
| 30 | 875337-44-3 | MGCD-265 analog |
≥98% | | 询价 |
| 31 | 252916-29-3 | Orantinib(SU 6668 NSC-702827 TSU68) |
≥98% | | 询价 |
| 32 | 288383-20-0 | Cediranib(NSC-732208 AZD-2171) |
≥98% | | 询价 |
| 33 | 852433-84-2 | Dovitinib Dilactic Acid(TKI258 CHIR258) |
≥98% | | 询价 |
| 34 | 1219168-18-9 | Dorsomorphin(Compound C)dihydrochloride |
| 5mg, 10mg, 50mg | 询价 |
| 35 | 212141-51-0 | Vatalanib(PTK-787 ZK222584 CGP79787)2HCl |
≥98% | | 询价 |
| 36 | 444731-52-6 | Pazopanib(GW 786034 Votrient) |
≥98% | | 询价 |
| 37 | 219580-11-7 | PD173074 |
≥98% | | 询价 |
| 38 | 649735-63-7 | Brivanib Alaninate(BMS-582664) |
≥98% | | 询价 |
| 39 | 927880-90-8 | RAF265(CHIR-265) |
≥98% | | 询价 |
| 40 | 635702-64-6 | Pazopanib HCl(GW-786034 GW786034 Votrient) |
≥98% | | 询价 |
| 41 | 728033-96-3 | OSI-930 |
≥98% | | 询价 |
| 42 | 417716-92-8 | Lenvatinib(E7080 ER-203492-00) |
≥98% | | 询价 |
| 43 | 405169-16-6 | Dovitinib(TKI-258,CHIR-258) |
≥98% | | 询价 |
| 44 | 649735-46-6 | Brivanib(BMS-540215) |
≥98% | | 询价 |
| 45 | 475108-18-0 | Tivozanib(AV951 KRN-951) |
≥98% | | 询价 |
| 46 | 497839-62-0 | AEE788(NVP-AEE788) |
≥98% | | 询价 |
| 47 | 811803-05-1 | Apatinib(Rivoceranib,YN968D1) |
≥98% | | 询价 |
| 48 | 228559-41-9 | Ki8751 |
≥98% | | 询价 |
| 49 | 1174046-72-0 | BMS-794833 |
≥98% | | 询价 |
| 50 | 1225451-84-2 | SKLB1002(SKLB-1002 SKLB 1002) |
≥98% | | 询价 |
| 51 | 208255-80-5 | DAPT |
| 5mg, 10mg, 50mg | 询价 |
| 52 | 1254473-64-7 | LY2874455 |
≥98% | | 询价 |
| 53 | 915769-50-5 | Dovitinib(TKI258 CHIR-258)Lactate |
≥98% | | 询价 |
| 54 | 557795-19-4 | Sunitinib free base(SU-11248) |
≥98% | | 询价 |
| 55 | 883986-34-3 | AZD2932 |
≥98% | | 询价 |
| 56 | 215543-92-3 | SU5402(SU-5402 SU 5402) |
≥98% | | 询价 |
| 57 | 443913-73-3 | Vandetanib(ZD-6474) |
≥98% | | 询价 |
| 58 | 849217-64-7 | Foretinib(GSK-1363089 XL-880 EXEL2880 GSK-089) |
≥98% | | 询价 |
| 59 | 319460-85-0 | Axitinib(AG-013736 Inlyta) |
≥98% | | 询价 |
| 60 | 943319-70-8 | Ponatinib(AP-24534 Iclusig) |
≥98% | | 询价 |
m.cnreagent.com